FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US

por Hoog, Meredith, Maldonado, Juan, Wangia-Dixon, Ruth, Halpern, Rachel, Buysman, Erin, Gremel, Garrett, Huang, Ahong, Konig, Manige
Publicado 2023

Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance...

por Hoog, Meredith, Paczkowski, Rosirene, Huang, Ahong, Halpern, Rachel, Buysman, Erin, Stackland, Sydnie, Zhang, Yiran, Wangia-Dixon, Ruth
Publicado 2023